(Q44673182)

English

Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (English)

1 reference

Europe PubMed Central

5 December 2017

neovascularization

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

author name string

Japanese Age-Related Macular Degeneration Tial (JAT) Study Group

1

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

5 December 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

American Journal of Ophthalmology

1 reference

Europe PubMed Central

5 December 2017

136

1 reference

Europe PubMed Central

5 December 2017

6

1 reference

Europe PubMed Central

5 December 2017

1049-1061

1 reference

Europe PubMed Central

5 December 2017

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Choroidal neovascularization in black patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Symptomatic age-related macular degeneration in Asian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

The second eye of Japanese patients with unilateral exudative age related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Pathologic myopia: where are we now?.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Laser treatments with verteporfin therapy and its potential impact on retinal practices

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900576-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9394(03)00576-2

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44673182&oldid=2031303748"